Delphi Genetics, part of Catalent Employee Directory

BiotechnologyWallonia, Belgium11-50 Employees

Delphi Genetics is a biotechnology research firm based in Charleroi, Wallonia, and operates as part of Catalent following its 2021 acquisition. It focuses on the bioproduction of plasmid DNA and recombinant proteins, including antibodies, offering both production capabilities and development services. The company relies on its expertise in stabilization systems and genetic engineering to improve yields in bacterial and mammalian cell production. Its patent covers a stabilization-based approach that increases the yield of recombinant protein and plasmid DNA production in E. coli without antibiotics. 
Delphi Genetics serves clients developing gene therapies and DNA vaccines, as well as biotechs seeking plasmid DNA, recombinant proteins, or antibody development. It provides custom production using E. coli and mammalian cells and is expanding GMP-capable facilities to supply high-quality plasmid DNA for gene therapy, naked DNA, and viral-vector workflows.

Sign up for free to view info

Company overview Email format